Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$1.76 - $2.83 $640,992 - $1.03 Million
364,200 New
364,200 $921,000
Q1 2023

May 12, 2023

BUY
$2.13 - $3.6 $525,897 - $888,840
246,900 New
246,900 $630,000
Q3 2022

Nov 14, 2022

BUY
$0.63 - $5.47 $263,317 - $2.29 Million
417,964 Added 478.22%
505,364 $1.47 Million
Q2 2022

Aug 12, 2022

BUY
$4.27 - $8.26 $373,197 - $721,924
87,400 New
87,400 $395,000

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.